diaziquone has been researched along with Ovarian Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balducci, L; Khansur, T; Thigpen, JT; Vance, RB | 1 |
| Bramwell, V; Dombernowsky, P; Hansen, HH; Lund, B; Renard, J | 1 |
| Blessing, JA; Homesley, HD; Park, R; Slayton, RE; Sutton, GP | 1 |
1 review(s) available for diaziquone and Ovarian Neoplasms
| Article | Year |
|---|---|
New drugs and experimental approaches in ovarian cancer treatment.
Topics: Altretamine; Aminoacridines; Amsacrine; Antineoplastic Agents; Aziridines; Benzoquinones; Busulfan; Carboplatin; Cisplatin; Estrogen Antagonists; Female; Galactitol; Humans; Ifosfamide; Mitomycins; Organoplatinum Compounds; Ovarian Neoplasms; Prednimustine; Progestins | 1984 |
2 other study(ies) available for diaziquone and Ovarian Neoplasms
| Article | Year |
|---|---|
Phase II trial of diaziquone in advanced ovarian carcinoma. European Organization for Research on Treatment of Cancer Early Clinical Trials Group.
Topics: Adult; Aged; Aziridines; Azirines; Benzoquinones; Cystadenocarcinoma; Drug Evaluation; Female; Gastrointestinal Hemorrhage; Humans; Leukopenia; Middle Aged; Nausea; Neoplasm Metastasis; Ovarian Neoplasms; Vomiting | 1985 |
Phase II clinical trial of diaziquone in the treatment of patients with epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Drug Evaluation; Female; Humans; Middle Aged; Ovarian Neoplasms | 1986 |